Anti-thymocyte Globulin (equine)

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameAnti-thymocyte Globulin (equine)
Drug Alias NameAtgamLympho globulinePF-06462700
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantationDiabetes Mellitus, Type 1Anemia, Aplastic
Global Approved IndicationsRejection of organ transplantationAnemia, Aplastic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date1991/08/01
Country/TerritoryUnited StatesAustraliaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationDiabetes Mellitus, Type 1Anemia, Aplastic
Inactive IndicationsN/A

Other Information

ATC CodeL04AA03
Related LinksWikipedia